Cargando…
P1034: HEALTHCARE UTILIZATION OF PATIENTS WITH HYPEREOSINOPHILIC SYNDROME IN EUROPE
Autores principales: | Hwee, J., Kwon, N., Alfonso-Cristancho, R., Baylis, L., Requena, G., Du, S., Khanal, A., Huynh, L., Duh, M. S., Jakes, R. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430700/ http://dx.doi.org/10.1097/01.HS9.0000847004.53726.7b |
Ejemplares similares
-
P1035: COUNTRY DIFFERENCES IN THE BURDEN OF PATIENTS WITH HYPEREOSINOPHILIC SYNDROME IN EUROPE
por: Hwee, J., et al.
Publicado: (2022) -
Response to a case report: Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab
por: Requena, Gema, et al.
Publicado: (2021) -
P1034: FROM SNAPSHOT TO CONTINUUM: CUMULATIVE TIME IN RESPONSE AS AN EMERGING PROXY FOR THROMBOTIC RISK IN POLYCYTHEMIA VERA
por: Gisslinger, Heinz, et al.
Publicado: (2023) -
Parameter Space Beyond “1034”
por: Zimmermann, F
Publicado: (2010) -
Parameter Space Beyond 1034
por: Zimmermann, F
Publicado: (2010)